Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Blue Bear Ventures (BBV) is a venture capital firm based in the United States, dedicated to supporting deep technology startups. Founded to address significant global challenges, BBV collaborates with leading research institutions such as UC Berkeley, MIT, and Stanford. The firm currently manages a portfolio of 12 companies, focusing on early-stage investments in frontier technology, biotech, healthcare, and climate sectors.
BBV invests in pre-seed, seed, and seed-plus stages, targeting deep tech companies that develop solutions in applied biology and emerging technologies. The firm emphasizes collaboration between corporates and startups, providing guidance and resources to help early-stage companies navigate growth and bring breakthrough technologies to market.
Notable portfolio companies include Aether, which engineers enzymes for biological manufacturing; Aluna, a smart respiratory health management system; Ayar Labs, miniaturizing fiber optic transceivers; Clarity, offering air quality monitoring solutions; and GenEdit, transforming gene therapy delivery.
Submit your pitch through their form at bbv.io.
Yes, BBV often leads investment rounds, particularly in the early stages of funding.
BBV is open to follow-on investments, especially for companies that demonstrate significant growth potential and alignment with their focus areas.
The specific size of BBV's current fund is not publicly disclosed, but they actively manage a portfolio of 12 companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.